TOGGLE MENU TOGGLE SEARCH HOME INVESTORS Corporate governance The Corporate Governance of Freeline is responsible for managing the business and overseeing the standards and procedures that drive us forward. It is the responsibility of the Board of Directors to oversee management of the Business in the best interest of Freeline, and to ensure it follows the procedures and standards set forth. Board of directors Professor Amit Nathwani Founder, Clinical and Scientific Adviser and Director READ BIO Martin Andrews Non-Executive Director READ BIO Chris Hollowood Chairman of the Board of Directors READ BIO Julia P Gregory Non-Executive Director READ BIO Jeffrey Chodakewitz Non-Executive Director READ BIO Colin Love Non-Executive Director READ BIO Michael Parini Chief Executive Officer and Director READ BIO Committee composition Name Audit Committee Remuneration Committee Nominating and Corporate Governance Committee Professor Amit Nathwani Member Martin Andrews Member Member Chris Hollowood Chair Julia P Gregory Chair Member Jeffrey Chodakewitz Member Chair Colin Love Member Member = Member Chair = Chair Governance documents Freeline Code of Conduct DOWNLOAD PDF (0.36MB) Freeline Whistleblower Policy DOWNLOAD PDF (0.23MB) Committee charters Freeline Audit Committee Charter DOWNLOAD PDF (0.24MB) Freeline Nominating and Corporate Governance Committee Charter DOWNLOAD PDF (0.16MB) Freeline Remuneration Committee Charter DOWNLOAD PDF (0.19MB) Get in touch T. Telephone: +44 (0)1438 906870 E. Email: contact@freeline.life Follow us on our social channels About us Innovation Patients & families Healthcare professionals Careers Investors Contact Terms of use Privacy Notice Accessibility Cookie Policy ©2021 Freeline

TOGGLE MENU TOGGLE SEARCH HOME INVESTORS Newsroom PRESS RELEASES EVENTS PRESENTATIONS Showing 1 to 7 of 19 presentations Freeline Corporate Presentation November 2021 09 November 2021 Freeline Corporate Presentation November 2021 FREELINE CORPORATE PRESENTATION NOVEMBER 2021 (6.07MB) Development of a 96-Well Plate-Based High-Throughput System for rAAV Manufacturing Platform Optimization and Candidate Selection 11 May 2021 VIEW PRESENTATION VIDEO Development and Scale Up of a Suspension Cell-Based AAV Manufacturing Process 11 May 2021 VIEW PRESENTATION VIDEO Defining a Reliable Quantification Assay Strategy for Adeno-Associated Virus (AAV)-Based Gene Therapies 11 May 2021 VIEW PRESENTATION VIDEO Development of an Assay to Measure Transduction Efficiency of Adeno-Associated Virus (AAV)-Based Gene Therapies 11 May 2021 VIEW PRESENTATION VIDEO GLA Uptake and Metabolic Cross Correction in Fabry Disease Relevant Cell Lines: A Rationale for Liver-Directed AAV Gene Therapy 11 May 2021 VIEW PRESENTATION VIDEO Previous 1 2 3 4 Next For all media enquiries please get in touch media@freeline.life Get in touch T. Telephone: +44 (0)1438 906870 E. Email: contact@freeline.life Follow us on our social channels About us Innovation Patients & families Healthcare professionals Careers Investors Contact Terms of use Privacy Notice Accessibility Cookie Policy ©2021 Freeline